Did you mean
promega, list

Search results - 11 results

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

Launay, Odile; Sarah Denayer; Seyler, Lucie; Baruch, Joaquin; Burgui, Cristina; Loghin, Isabela I; Domegan, Lisa; Vaikutyte, Roberta; Husa, Petr; Panagiotakopoulos, George; Aouali, Nassera; Dürrwald, Ralf; ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

Seyler, Lucie; Domegan, Lisa; Launay, Odile; Machado, Ausenda; Burgui, Cristina; Vaikutyte, Roberta; Niessen, F Annabel; Loghin, Isabela I; Husa, Petr; Aouali, Nassera; Panagiotakopoulos, George; Tolksdorf, ...

Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.

Paula; Bennett, Charlene; Domegan, Lisa; Kalaveshi, Arijana; Jakupi, Xhevat; Ovliyakulova, Gurbangul; Korsun, Neli; Vladimirova, Nadezhda Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Seyler, Lucie; Domegan, Lisa; Launay, Odile; Machado, Ausenda; Burgui, Cristina; Vaikutyte, Roberta; Niessen, F Annabel; Loghin, Isabela I; Husa, Petr; Aouali, Nassera; Panagiotakopoulos, George; Tolksdorf, ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Launay, Odile; Denayer, Sarah; Seyler, Lucie; Baruch, Joaquin; Burgui, Cristina; Loghin, Isabela I; Domegan, Lisa; Vaikutyte, Roberta; Husa, Petr; Panagiotakopoulos, George; Aouali, Nassera; Dürrwald, Ralf; ...

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.

Kynčl; Pavel Slezak; Mia Brytting; Raquel Guiomar; Monika Redlberger-Fritz; Jackie Maistre Melillo; Tanya Melillo; Arianne B van Gageldonk-Lafeber; Sierk D Marbus; O'Donnell, Joan; Domegan, Lisa ...

Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

Bobvos, Janos; Paldy, Anna; Naama Rotem; Irene Kornilenko; Domegan, Lisa; Joan O’Donnell; Francesca De Donato; Scortichini, Matteo; Patrick Hoffmann; Telma Velez; England, Kathleen; Calleja, Neville; van ...

Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020

Oskari Luomala; Teemu Möttönen; Fouillet, Anne; Céline Caserio-Schönemann; Matthias Van der Heiden; Helmut Uphoff; Lytras, Theodore; Gkolfinopoulou, Kassiani; Paldy, Anna; Domegan, Lisa; O'Donnell, ...

European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

Gleb; Innos, Kaire; Virtanen, Mikko J; Fouillet, Anne; Lytras, Theodore; Gkolfinopoulou, Kassiani; Matthias Van der Heiden; Linus Grabenhenrich; Helmut Uphoff; Paldy, Anna; Bobvos, Janos; Domegan, Lisa ...

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.

Kaire; Virtanen, Mikko J; Fouillet, Anne; Lytras, Theodore; Paldy, Anna; Bobvos, Janos; Domegan, Lisa; O'Donnell, Joan; Scortichini, Matteo; de Martino, Annamaria; England, Kathleen; Calleja, Neville; ...

QR code

QR code for this page URL